Alterity Therapeutics (ATHE) Change in Accured Expenses (2016 - 2020)
Alterity Therapeutics' (ATHE) quarterly Change in Accured Expenses came in at -$1033.6 in Q2 2020, up 97.85% quarter-over-quarter from -$48058.2 in Q4 2019.
Alterity Therapeutics (ATHE) Change in Accured Expenses (2016 - 2020) Analysis & Trends
Alterity Therapeutics' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at -$1033.6 for Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -16.74 Mn |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -1,033.60 |
| Jun 30, 2020 | -1,033.60 |
| Dec 31, 2019 | -48,058.24 |
| Dec 31, 2019 | -48,058.24 |
| Jun 30, 2016 | -9,017.18 |
| Jun 30, 2016 | -9,017.18 |